Yu Kyeong Hwang

Title: Yu Kyeong Hwang: Innovator in Immunotherapy

Introduction

Yu Kyeong Hwang is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of immunotherapy, particularly in the development of chimeric antigen receptors and natural killer cells. With a total of 6 patents to his name, Hwang's work is paving the way for advancements in cancer treatment.

Latest Patents

Hwang's latest patents include groundbreaking inventions that enhance the efficacy of immune cells in combating cancer. One of his notable patents is for a chimeric antigen receptor and natural killer cells expressing the same. This invention provides a chimeric antigen receptor (CAR) that includes an intracellular signaling domain featuring the whole or a portion of an OX40 ligand (CD252). This innovation significantly increases the anticancer activity of immune cells. Another important patent is a method for culturing cord blood-derived natural killer cells using transformed T-cells. This method allows for the effective proliferation and production of natural killer cells from a small amount of seed cells, improving their cytotoxicity and making them valuable for cell therapy.

Career Highlights

Throughout his career, Yu Kyeong Hwang has worked with notable organizations such as GC Cell Corporation and Mogam Biotechnology Research Institute. His experience in these companies has contributed to his expertise in the field of biotechnology and immunotherapy.

Collaborations

Hwang has collaborated with several professionals in his field, including Bokyung Min and Hyun Ah Kim. These collaborations have further enriched his research and development efforts.

Conclusion

Yu Kyeong Hwang is a distinguished inventor whose work in immunotherapy is making a significant impact on cancer treatment. His innovative patents and collaborations highlight his commitment to advancing medical science.